BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wawrocki S, Seweryn M, Kielnierowski G, Rudnicka W, Wlodarczyk M, Druszczynska M. IL-18/IL-37/IP-10 signalling complex as a potential biomarker for discriminating active and latent TB. PLoS One 2019;14:e0225556. [PMID: 31821340 DOI: 10.1371/journal.pone.0225556] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Koyuncu D, Niazi MKK, Tavolara T, Abeijon C, Ginese ML, Liao Y, Mark C, Specht A, Gower AC, Restrepo BI, Gatti DM, Kramnik I, Gurcan M, Yener B, Beamer G. CXCL1: A new diagnostic biomarker for human tuberculosis discovered using Diversity Outbred mice. PLoS Pathog 2021;17:e1009773. [PMID: 34403447 DOI: 10.1371/journal.ppat.1009773] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Delemarre EM, van Hoorn L, Bossink AWJ, Drylewicz J, Joosten SA, Ottenhoff THM, Akkerman OW, Goletti D, Petruccioli E, Navarra A, van den Broek BTA, Paardekooper SPA, van Haeften I, Koenderman L, Lammers JJ, Thijsen SFT, Hofland RW, Nierkens S. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Front Immunol 2021;12:725447. [PMID: 34691031 DOI: 10.3389/fimmu.2021.725447] [Reference Citation Analysis]
3 Wawrocki S, Kielnierowski G, Rudnicka W, Seweryn M, Druszczynska M. Interleukin-18, Functional IL-18 Receptor and IL-18 Binding Protein Expression in Active and Latent Tuberculosis. Pathogens 2020;9:E451. [PMID: 32521630 DOI: 10.3390/pathogens9060451] [Reference Citation Analysis]
4 Jafrasteh A, Karimi A, Hoseinialfatemi SM, Azimi L, Tabarsi P, Nasehi M, Naseri M, Panahi Mishkar A, Sheikhi M, Mansour Ghanaie R. Evaluation of Interleukin-2 to Detect Active and Latent Tuberculosis among Household Contacts of Pulmonary Tuberculosis Cases. Arch Pediatr Infect Dis 2021;9. [DOI: 10.5812/pedinfect.109398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wawrocki S, Seweryn M, Kielnierowski G, Rudnicka W, Druszczynska M. IL-18 and related function proteins associated with tuberculosis severity and screening for active TB among patients with non-mycobacterial community-acquired pneumonia (CAP). Saudi J Biol Sci 2020;27:3035-45. [PMID: 33100863 DOI: 10.1016/j.sjbs.2020.09.003] [Reference Citation Analysis]
6 Flores J, Cancino JC, Chavez-Galan L. Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It? Front Microbiol 2021;12:638047. [PMID: 33935997 DOI: 10.3389/fmicb.2021.638047] [Reference Citation Analysis]
7 Konrad ER, Soo J, Conroy AL, Namasopo S, Opoka RO, Hawkes MT. Interleukin-18 binding protein in infants and children hospitalized with pneumonia in low-resource settings. Cytokine 2021;150:155775. [PMID: 34875584 DOI: 10.1016/j.cyto.2021.155775] [Reference Citation Analysis]
8 Padmapriyadarsini C, Sachdeva KS, Nair D, Ramachandran R. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries. Expert Rev Respir Med 2021;15:899-910. [PMID: 33302729 DOI: 10.1080/17476348.2021.1862652] [Reference Citation Analysis]